Mach7 Technologies Future Growth
Future criteria checks 4/6
Mach7 Technologies is forecast to grow earnings and revenue by 90.3% and 18.3% per annum respectively. EPS is expected to grow by 90.3% per annum. Return on equity is forecast to be 8.8% in 3 years.
Key information
90.3%
Earnings growth rate
90.3%
EPS growth rate
Healthcare Services earnings growth | 22.7% |
Revenue growth rate | 18.3% |
Future return on equity | 8.8% |
Analyst coverage | Low |
Last updated | 28 Aug 2024 |
Recent future growth updates
Recent updates
Investors Interested In Mach7 Technologies Limited's (ASX:M7T) Revenues
Aug 01Mach7 Technologies Limited (ASX:M7T) Analysts Are More Bearish Than They Used To Be
Jan 29Mach7 Technologies (ASX:M7T) Is In A Strong Position To Grow Its Business
Nov 23Is Now The Time To Look At Buying Mach7 Technologies Limited (ASX:M7T)?
Sep 29Estimating The Fair Value Of Mach7 Technologies Limited (ASX:M7T)
Sep 04Why Mach7 Technologies Limited (ASX:M7T) Could Be Worth Watching
Jun 13We're Interested To See How Mach7 Technologies (ASX:M7T) Uses Its Cash Hoard To Grow
Apr 28An Intrinsic Calculation For Mach7 Technologies Limited (ASX:M7T) Suggests It's 47% Undervalued
Oct 24Are Investors Undervaluing Mach7 Technologies Limited (ASX:M7T) By 37%?
Jun 23Is Mach7 Technologies Limited (ASX:M7T) Potentially Undervalued?
May 19Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 47% Undervaluation?
Nov 10Mach7 Technologies Limited's (ASX:M7T) Analyst Just Slashed This Year's Estimates
Jul 27Upgrade: The Latest Revenue Forecasts For Mach7 Technologies Limited (ASX:M7T)
Feb 19The Mach7 Technologies (ASX:M7T) Share Price Is Up 303% And Shareholders Are Delighted
Jan 27Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 46% Undervaluation?
Dec 06Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2027 | 51 | 2 | N/A | 7 | 2 |
6/30/2026 | 47 | 1 | N/A | 5 | 4 |
6/30/2025 | 38 | -6 | N/A | -1 | 4 |
6/30/2024 | 30 | -8 | 3 | 3 | N/A |
3/31/2024 | 29 | -7 | 3 | 3 | N/A |
12/31/2023 | 27 | -6 | 2 | 2 | N/A |
9/30/2023 | 29 | -3 | 0 | 0 | N/A |
6/30/2023 | 30 | -1 | -3 | -3 | N/A |
3/31/2023 | 29 | -2 | -2 | -1 | N/A |
12/31/2022 | 28 | -4 | 0 | 0 | N/A |
9/30/2022 | 27 | -4 | 3 | 3 | N/A |
6/30/2022 | 26 | -4 | 6 | 6 | N/A |
3/31/2022 | 26 | -3 | 5 | 6 | N/A |
12/31/2021 | 26 | -3 | 5 | 5 | N/A |
9/30/2021 | 23 | -6 | 3 | 3 | N/A |
6/30/2021 | 19 | -9 | 1 | 1 | N/A |
3/31/2021 | 18 | -9 | 1 | 1 | N/A |
12/31/2020 | 17 | -8 | 0 | 0 | N/A |
9/30/2020 | 18 | -4 | 2 | 3 | N/A |
6/30/2020 | 19 | 0 | 5 | 5 | N/A |
3/31/2020 | 17 | -1 | 3 | 3 | N/A |
12/31/2019 | 15 | -2 | 1 | 1 | N/A |
9/30/2019 | 12 | -5 | -1 | -1 | N/A |
6/30/2019 | 9 | -7 | -3 | -3 | N/A |
3/31/2019 | 9 | -7 | -4 | -4 | N/A |
12/31/2018 | 8 | -6 | -4 | -4 | N/A |
9/30/2018 | 8 | -5 | -3 | -3 | N/A |
6/30/2018 | 9 | -5 | -2 | -2 | N/A |
3/31/2018 | 9 | -11 | N/A | -2 | N/A |
12/31/2017 | 9 | -17 | N/A | -3 | N/A |
9/30/2017 | 10 | -17 | N/A | -4 | N/A |
6/30/2017 | 10 | -18 | N/A | -5 | N/A |
3/31/2017 | 8 | -16 | N/A | -5 | N/A |
12/31/2016 | 6 | -15 | N/A | -4 | N/A |
9/30/2016 | 4 | -14 | N/A | -4 | N/A |
6/30/2016 | 2 | -13 | N/A | -3 | N/A |
12/31/2015 | 8 | -3 | N/A | N/A | N/A |
6/30/2015 | 0 | -7 | N/A | -2 | N/A |
12/31/2014 | 5 | -3 | N/A | N/A | N/A |
12/31/2013 | 3 | -4 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: M7T is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Earnings vs Market: M7T is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: M7T is expected to become profitable in the next 3 years.
Revenue vs Market: M7T's revenue (18.3% per year) is forecast to grow faster than the Australian market (5.3% per year).
High Growth Revenue: M7T's revenue (18.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: M7T's Return on Equity is forecast to be low in 3 years time (8.8%).